Proteome analysis of bronchoalveolar lavage fluid in chronic hypersensitivity pneumonitis

Allergology International

Volumn 61, Issue 1, 2012, Pages 83-92

  Okamoto, Tsukasa ^a   Miyazaki, Yasunari ^a   Shirahama, Ryutaro ^a   Tamaoka, Meiyo ^a   Inase, Naohiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Chronic hypersensitivity pneumonitis; Mass spectrometry; Proteomics; Surfactant protein A

Indexed keywords

ALBUMIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA 2 HEAT SHOCK GLYCOPROTEIN; ALPHA 2 MACROGLOBULIN; ALPHA1 GLYCOPROTEIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTITHROMBIN III; APOLIPOPROTEIN A1; BETA ACTIN; C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 BETA; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; HAPTOGLOBIN BETA; HEAT SHOCK PROTEIN; HEMOPEXIN; IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN ALPHA; IMMUNOGLOBULIN J CHAIN; PREALBUMIN; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR 1; TRANSFERRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ALLERGIC PNEUMONITIS; AMINO ACID SEQUENCE; ARTICLE; CHRONIC DISEASE; CHRONIC HYPERSENSITIVITY PNEUMONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROTIC NONSPECIFIC INTERSTITIAL PNEUMONIA; HUMAN; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; USUAL INTERSTITIAL PNEUMONIA;

EID: 84858307403     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-OA-0315     Document Type: Article

References (35)

1. Fink JN. Hypersensitivity pneumonitis. J Allergy Clin Immunol 1984;74:1-10.
2. Lacasse Y, Selman M, Costabel U et al. Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol 2009;149:161-166.
3. Ohtani Y, Saiki S, Sumi Y et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 2003;90:604-610.
4. Ohtani Y, Saiki S, Kitaichi M et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS_ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60: 665-671.
5. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
6. Yang I, Burch L, Steele M et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 2007;175:45-54.
7. Miyazaki Y, Tateishi T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008;134:1265-1270.
8. Wattiez R, Hermans C, Cruyt C, Bernard A, Falmagne P. Human bronchoalveolar lavage fluid protein twodimensional database: study of interstitial lung diseases. Electrophoresis 2000;21:2703-2712.
9. Kim T, Lee Y, Kim K et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med 2010;182:633-642.
10. He C. Proteomic analysis of human bronchoalveolar lavage fluid: expression profiling of surfactant-associated protein A isomers derived from human pulmonary alveolar proteinosis using immunoaffinity detection. Proteomics 2003;3:87-94.
11. Doyle I, Davidson K, Barr H, Nicholas T, Payne K, Pfitzner J. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med 1998;157:658-664.
12. Bai Y, Galetskiy D, Damoc E et al. High resolution mass spectrometric alveolar proteomics: identification of surfactant surfactant protein SP-A and SP-D modifications in proteinosis and cystic fibrosis patients. Proteomics 2004;4:2300-2309.
13. Ohlmeier S, Vuolanto M, Toljamo T et al. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 2008;7:5125-5132.
14. Fietta A, Bardoni A, Salvini R et al. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther 2006;8:R160.
15. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987;135:250-263.
16. Kishi M, Miyazaki Y, Jinta T et al. Pathogenesis of cBFL in common with IPF? Correlation of IP-10_TARC ratio with histological patterns. Thorax 2008;63:810-816.
17. Shirahama R, Miyazaki Y, Okamoto T, Inase N, Yoshizawa Y. Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis. Allergol Int 2010;59:409-415.
18. Wattiez R, Falmagne P. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005;815:169-178.
19. Vázquez de Lara L, Becerril C, Montano M et al. Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol 2000;279:L950-L957.
20. Phelps DS, Umstead TM, Mejia M, Carrillo G, Pardo A, Selman M. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. Chest 2004;125:617-625.
21. McCormack FX, King TE, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991;144:160-166.
22. Gunther A, Schmidt R, Nix F et al. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999;14:565-573.
23. Boon K, Bailey NW, Yang J et al. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009; 4:e5134.
24. Hamm H, Lührs J, Guzmany Rotaeche J, Costabel U, Fabel H, Bartsch W. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994;106:1766-1770.
25. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 2005;174:6943-6954.
26. Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 1998;16:833-838.
27. Fink AL. Chaperone-mediated protein folding. Physiol Rev 1999;79:425-449.
28. Xu Q, Schett G, Perschinka H et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000;102:14-20.
29. Feige U, Cohen IR. The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice. Springer Semin Immunopathol 1991;13:99-113.
30. Baumann H, Jahreis GP, Morella KK. Interaction of cytokine- and glucocorticoid-response elements of acutephase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. J Biol Chem 1990;265:22275-22281.
31. Yamamoto N, Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine- treated lymphocytes. Proc Natl Acad Sci U S A 1991;88:8539-43.
32. Binder R, Kress A, Kan G, Herrmann K, Kirschfink M. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol Immunol 1999;36:885-892.
33. Haddad JG, Hu YZ, Kowalski MA et al. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 1992;31:7174-7181.
34. Cantin AM, North SL, Fells GA, Hubbard RC, Crystal RG. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987;79:1665-1673.
35. Demedts M, Behr J, Buhl R et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2229-2242.